Details for: NOVOLIN GE
Company: NOVO NORDISK CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02024322 | NOVOLIN GE 50/50 PENFILL | INSULIN INJECTION HUMAN BIOSYNTHETIC; INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 50 UNIT / ML; 50 UNIT / ML | SUSPENSION | SUBCUTANEOUS |
| 02024314 | NOVOLIN GE 40/60 PENFILL | INSULIN INJECTION HUMAN BIOSYNTHETIC; INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 40 UNIT / ML; 60 UNIT / ML | SUSPENSION | SUBCUTANEOUS |
| 02025248 | NOVOLIN GE 30/70 PENFILL | INSULIN INJECTION HUMAN BIOSYNTHETIC; INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 30 UNIT / ML; 70 UNIT / ML | SUSPENSION | SUBCUTANEOUS |
| 02024217 | NOVOLIN GE 30/70 | INSULIN INJECTION HUMAN BIOSYNTHETIC; INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 30 UNIT / ML; 70 UNIT / ML | SUSPENSION | SUBCUTANEOUS |
| 02024225 | NOVOLIN GE NPH | INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 100 UNIT / ML | SUSPENSION | SUBCUTANEOUS |
| 02024268 | NOVOLIN GE NPH PENFILL | INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 100 UNIT / ML | SUSPENSION | SUBCUTANEOUS |
| 02024233 | NOVOLIN GE TORONTO | INSULIN INJECTION HUMAN BIOSYNTHETIC | 100 UNIT / ML | SOLUTION | INTRAMUSCULAR |
| 02024284 | NOVOLIN GE TORONTO PENFILL | INSULIN INJECTION HUMAN BIOSYNTHETIC | 100 UNIT / ML | SOLUTION | SUBCUTANEOUS |
| 02024233 | NOVOLIN GE TORONTO | INSULIN INJECTION HUMAN BIOSYNTHETIC | 100 UNIT / ML | SOLUTION | SUBCUTANEOUS |
| 02024284 | NOVOLIN GE TORONTO PENFILL | INSULIN INJECTION HUMAN BIOSYNTHETIC | 100 UNIT / ML | SOLUTION | INTRAMUSCULAR |
| 02024233 | NOVOLIN GE TORONTO | INSULIN INJECTION HUMAN BIOSYNTHETIC | 100 UNIT / ML | SOLUTION | INTRAVENOUS |
| 02024284 | NOVOLIN GE TORONTO PENFILL | INSULIN INJECTION HUMAN BIOSYNTHETIC | 100 UNIT / ML | SOLUTION | INTRAVENOUS |
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.